Akoustis Technologies (AKTS)
NASDAQ:AKTS
Holding AKTS?
Track your performance easily

Akoustis Technologies (AKTS) Technical Analysis

979 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Akoustis Technologies’s (AKTS) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Akoustis Technologies is a Sell.
Akoustis Technologies’s (AKTS) 20-Day exponential moving average is 0.07, while Akoustis Technologies’s (AKTS) share price is <$0.1, making it a Sell.
Akoustis Technologies’s (AKTS) 50-Day exponential moving average is 0.10, while Akoustis Technologies’s (AKTS) share price is <$0.1, making it a Sell.

Akoustis Technologies (AKTS) Pivot Points

Sep 20, 2024, 01:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.05
0.05
0.06
0.06
0.06
0.06
0.07
Fibonacci
0.05
0.05
0.06
0.06
0.06
0.06
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akoustis Technologies (AKTS) Moving Averages

Sep 20, 2024, 01:52 AM
Period
Simple
Exponential
MA5
0.06Buy
0.06Buy
MA10
0.06Buy
0.06Buy
MA20
0.07Sell
0.07Sell
MA50
0.09Sell
0.10Sell
MA100
0.18Sell
0.19Sell
MA200
0.41Sell
0.37Sell
Akoustis Technologies’s (AKTS) 10-Day exponential moving average is 0.06, while Akoustis Technologies’s (AKTS) share price is <$0.1, making it a Buy.
Akoustis Technologies’s (AKTS) 100-Day exponential moving average is 0.19, while Akoustis Technologies’s (AKTS) share price is <$0.1, making it a Sell.
Akoustis Technologies’s (AKTS) stock price is <$0.1 and Akoustis Technologies’s (AKTS) 50-day simple moving average is 0.09, creating a Sell signal.
Akoustis Technologies’s (AKTS) stock price is <$0.1 and Akoustis Technologies’s (AKTS) 100-day simple moving average is 0.18, creating a Sell signal.
Akoustis Technologies’s (AKTS) stock price is <$0.1 and Akoustis Technologies’s (AKTS) 200-day simple moving average is 0.41, creating a Sell signal.

Akoustis Technologies (AKTS) Technical Indicators

Sep 20, 2024, 01:52 AM
Name
Value
Implied Action
RSI (14)
44.93
Neutral
STOCH (9,6)
48.64
Neutral
STOCHRSI (14)
29.26
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
15.49
Buy
Williams %R
-48.48
Buy
CCI (14)
-49.95
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
48.66
Neutral
ROC
-12.50
Sell
Akoustis Technologies’s (AKTS) Relative Strength Index (RSI) is 44.93, creating a Neutral signal.
Akoustis Technologies’s (AKTS) Trend Strength Indicator (ADX) is 15.49, creating a Buy signal.
Akoustis Technologies’s (AKTS) Commodity Channel Index (CCI) is -49.95, creating a Neutral signal.
Akoustis Technologies’s (AKTS) Price Rate of Change (ROC) is -12.50, creating a Sell signal.

FAQ

Is AKTS a Buy, Hold, or Sell?
Based on AKTS’s technical indicators, AKTS is a Sell.
    What is AKTS’s RSI (14)?
    AKTS’s RSI (14) is 44.93, which suggests AKTS is a Neutral.
      What is AKTS’s MACD?
      AKTS’s MACD is -0.01, which suggests AKTS is a Sell.
        What is AKTS’s 5-day moving average?
        AKTS’s 5-day moving average is 0.06, which suggests AKTS is a Buy.
          What is AKTS’s 20-day moving average?
          AKTS 20-day moving average is 0.07, which suggests AKTS is a Sell.
            What is AKTS’s 50-day moving average?
            AKTS’s 50-day moving average is 0.09, which suggests AKTS is a Sell.
              What is AKTS’s 200-day moving average?
              AKTS’s 200-day moving average is 0.41, which suggests AKTS is a Sell.
                What is AKTS’s Williams % R (14)?
                AKTS’s Williams % R (14) is -48.48, which suggests AKTS is a Buy.
                  What is AKTS’s CCI (14)?
                  AKTS’s CCI (14) is -49.95, which suggests AKTS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis